drugset / Trial / NCT00058838
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to determine whether sumanirole, at three different dose levels, is effective and safe in the treatment of the signs and symptoms of early Parkinson's disease
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sumanirole | Small molecule | — | — |